Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Qingdao Institute Of Marine Bioresources For Nutrition & Health Innovation has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to LEVIN, JOEL D, who is the 1 examiner and the busiest examiner with 1 pending file. The prosecution is localized in 1 distinct art unit, reflecting a focused technical review. For a practitioner, the concentration of 1 pending office action under 1 examiner means that the immediate prosecution strategy is singular.
There is no need to coordinate across different art units or examiner styles. LEVIN, JOEL D, as the busiest examiner with 1 pending action, handles the entirety of the institute's current USPTO workload. Practitioners should focus on establishing a clear dialogue with LEVIN, JOEL D to resolve the outstanding action efficiently. This streamlined prosecution profile indicates that the institute's current USPTO activity is limited to a specific technical niche within the broader Biotechnology & Pharmaceuticals field. The administrative overhead is minimal given the low volume of pending matters, allowing for a dedicated focus on the 1 distinct art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEVIN, JOEL D | 1 | 58.1% | +35.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18813100 | METHOD FOR CO-CULTIVATION AND DIRECTED DIFFERENTIATION INDUCTION OF MUSCLE SATELLITE CELLS AND ADIPOSE-DERIVED STEM CELLS | LEVIN, JOEL D | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18813100 | METHOD FOR CO-CULTIVATION AND DIRECTED DIFFERENTIATION INDUCTION OF MUSCLE SATELLITE CELLS AND ADIPOSE-DERIVED STEM CELLS | LEVIN, JOEL D | 1633 | §112 | Non-Final OA | — | Pending | Aug 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQingdao Institute Of Marine Bioresources For Nutrition & Health Innovation has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joel D Levin has the most, with 1 of Qingdao Institute Of Marine Bioresources For Nutrition & Health Innovation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
